MimiVax is a developer of immunotherapeutic vaccines and targeted therapies used to control tumor growth and recurrence.
MimiVax's investors include MEDA Angels, Varia Ventures, Brain Tumor Investment Fund, Sontag Family Trust.
MimiVax is headquartered in Buffalo, United States.
MimiVax is a developer of immunotherapeutic vaccines and targeted therapies used to control tumor growth and recurrence.
MimiVax is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MimiVax — Funding & Investors." VCBacked, January 9, 2024, https://www.vcbacked.co/company/mimivax. Accessed August 17, 2026.
VCBacked. (2024). MimiVax — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/mimivax
{{cite web |title=MimiVax — Funding & Investors |url=https://www.vcbacked.co/company/mimivax |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated